The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Oct. 11, 2022

Filed:

Feb. 22, 2018
Applicant:

Amgen Inc., Thousand Oaks, CA (US);

Inventors:

Christopher James Sloey, Newbury Park, CA (US);

Sekhar Kanapuram, Thousand Oaks, CA (US);

Huanchun Cui, Aesch, CH;

Chio Mui Chan, Hillsboro, OR (US);

Elaheh Binabaji, Los Angeles, CA (US);

Assignee:

AMGEN INC., Thousand Oaks, CA (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 39/395 (2006.01); C07K 16/40 (2006.01); A61K 47/18 (2017.01); C07K 1/36 (2006.01); A61K 9/00 (2006.01); C07K 1/16 (2006.01); C07K 16/06 (2006.01); C07K 16/22 (2006.01);
U.S. Cl.
CPC ...
A61K 39/3955 (2013.01); A61K 9/0019 (2013.01); A61K 39/39591 (2013.01); A61K 47/183 (2013.01); C07K 1/16 (2013.01); C07K 1/36 (2013.01); C07K 16/40 (2013.01); C07K 16/065 (2013.01); C07K 16/22 (2013.01); C07K 2317/565 (2013.01); C07K 2317/76 (2013.01); C07K 2317/90 (2013.01);
Abstract

Provided herein are formulations of PCSK9-binding polypeptides, such as those comprising evolocumab, that comprise N-acetyl arginine and have reduced viscosities when compared to formulations lacking N-acetyl arginine. Provided herein are also methods of formulating such compositions that are advantageous in that they conserve certain components. Such formulations comprising PCSK9-binding polypeptides can be administered to patients to treat and/or prevent PCSK9-related diseases, conditions, and disorders.


Find Patent Forward Citations

Loading…